Literature DB >> 29023926

Hyperthyroidism in patients with ischaemic heart disease after iodine load induced by coronary angiography: Long-term follow-up and influence of baseline thyroid functional status.

Nadia Bonelli1, Ruth Rossetto1, Davide Castagno2, Matteo Anselmino2, Francesca Vignolo1, Mirko Parasiliti Caprino1, Fiorenzo Gaita2, Ezio Ghigo1, Roberto Garberoglio1, Roberto Grimaldi2, Mauro Maccario1.   

Abstract

OBJECTIVE: To study the effect of a iodine load on thyroid function of patients with ischaemic heart disease (IHD) and the long-term influence of unknown subclinical hyperthyroidism. CONTEXT: Subclinical hyperthyroidism is considered an independent risk factors for cardiovascular morbidity of patients with IHD. They routinely undergo coronary angiography with iodine contrast media (ICM) which may induce or even worsen hyperthyroidism.
DESIGN: A cross-sectional study followed by a longitudinal study on patients with subclinical hyperthyroidism. PATIENTS: 810 consecutive IHD outpatients without known thyroid diseases or treatment with drugs influencing thyroid activity undergoing elective coronary angiography. MEASUREMENTS: We evaluated thyroid function either before and 1 month after ICM; patients with thyrotoxicosis at baseline or after ICM were then followed up for 1 year.
RESULTS: 58 patients had hyperthyroidism at baseline (HB, 7.2%), independently associated to FT4 levels, thyroid nodules and family history of thyroid diseases. After ICM, the prevalence of hyperthyroidism was 81 (10%). Hyperthyroidism after ICM was positively predicted by baseline fT4 levels, thyroid nodules, age over 60, male gender, family history of thyroid diseases. Three months after ICM, 34 patients (4.2%) still showed hyperthyroidism (22 from HB, 13 treated with methimazole). One year after ICM, hyperthyroidism was still present in 20 patients (2.5%, all from HB, 13 treated).
CONCLUSIONS: The prevalence of spontaneous subclinical hyperthyroidism in IHD is surprisingly elevated and is further increased by iodine load, particularly in patients with thyroid nodules and familial history of thyroid diseases, persisting in a not negligible number of them even after one year.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  iodine; ischaemic heart disease; thyroid function

Mesh:

Substances:

Year:  2017        PMID: 29023926     DOI: 10.1111/cen.13494

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  6 in total

1.  Coronary physiology and percutaneous intervention managed with gadolinium road mapping and intravascular ultrasound in hyperthyroidism.

Authors:  Peter Tajti; Mohamed Ayoub; Thomas Nuehrenberg; Kambis Mashayekhi
Journal:  Cardiol J       Date:  2021-03-01       Impact factor: 2.737

2.  Percutaneous Coronary Intervention for Chronic Total Occlusion versus Percutaneous Coronary Intervention for Non-Complex Coronary Lesions: Is There a Different Impact on Thyroid Function?

Authors:  Çağın Mustafa Üreyen; Kahraman Coşansu; Mustafa Gökhan Vural; Sait Emir Şahin; Mehmet Akif Çakar; Harun Kılıç; Mustafa Tarık Ağaç; Hüseyin Gündüz; Ramazan Akdemir; Ersan Tatlı
Journal:  Med Princ Pract       Date:  2019-09-20       Impact factor: 1.927

3.  2021 European Thyroid Association Guidelines for the Management of Iodine-Based Contrast Media-Induced Thyroid Dysfunction.

Authors:  Tomasz Bednarczuk; Thomas H Brix; Wolfgang Schima; Georg Zettinig; George J Kahaly
Journal:  Eur Thyroid J       Date:  2021-06-16

4.  Prevention of Iodinated Contrast Media-Induced Hyperthyroidism in Patients with Euthyroid Goiter.

Authors:  Katarzyna Pelewicz; Rafał Wolny; Tomasz Bednarczuk; Piotr Miśkiewicz
Journal:  Eur Thyroid J       Date:  2021-04-13

5.  Impact of Iodinated Contrast Media in Patients Received Percutaneous Coronary Intervention: Focus on Thyroid Disease.

Authors:  Yasha Chen; Xueyang Zheng; Na Li; Wenhao Niu; Bowen Hu; Xun Yuan; Chun Liang; Yunling Lin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

6.  Heart failure as a serious complication of iodinated contrast-induced hyperthyroidism: case-report.

Authors:  Sofie M Diepenbroek; A de Jonghe; C van Rees; E Seebus
Journal:  BMC Endocr Disord       Date:  2021-10-20       Impact factor: 2.763

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.